Roche seeks FDA approval for new cervical cancer test | July 12, 2013 | Pleasanton Weekly | PleasantonWeekly.com |


http://pleasantonweekly.com/print/story/print/2013/07/12/roche-seeks-fda-approval-for-new-cervical-cancer-test


Pleasanton Weekly

- July 12, 2013

Roche seeks FDA approval for new cervical cancer test

Expanded indication would allow biotech firm's Cobas Test to take lead in cervical screening strategy

by Jeb Bing

Roche, one of the world's largest biotech companies with operations in Pleasanton's Hacienda Business Park, has submitted a request to the U.S. Food and Drug Administration (FDA) seeking the addition of a cervical cancer primary screening indication for the Cobas HPV Test.

This story contains 282 words.

If you are a paid subscriber, check to make sure you have logged in. Otherwise our system cannot recognize you as having full free access to our site.

If you are a paid print subscriber and haven't yet set up an online account, click here to get your online account activated.

Comments

There are no comments yet for this post